nach oben

Erschienen in:

12.01.2021 | Original Paper

Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial

verfasst von: Irving Llibran Reyna-Rodríguez, Sonia Chavez-Alvarez, Veronica Garza-Rodríguez, Rodolfo Franco-Marquez, Gerardo Gonzalez-Martinez, Jorge Ocampo-Candiani, Alejandra Villarreal-Martinez

Erschienen in: Archives of Dermatological Research | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Anogenital warts are a common human papillomavirus infection. They cause emotional distress, especially when they are in the anogenital region. Cryotherapy is a first-line treatment. Previous clinical trials and case series have reported variable results with retinoids (isotretinoin) as adjuvant therapy.

Objective

To determine the safety and efficacy of low-dose oral isotretinoin as adjuvant treatment of anogenital warts.

Methods

Forty-six patients with anogenital warts were randomly assigned to isotretinoin + cryotherapy (n = 23) or only cryotherapy (n = 23). Patients were allocated via an interactive web-based randomization system. Evaluators were blinded to treatments. Isotretinoin 20 mg/daily + cryotherapy or cryotherapy were prescribed for 6 weeks. Patients were followed for 4 months. Genotyping of lesions was performed before treatment started. Dermatology Life Quality Index (DLQI) and Columbia-Suicide Severity Rating Scale (C-SSRS) were measured at the beginning and end of therapy. All patients completed the study.

Results

Both Groups had 50% clearance at the end of treatment. Recurrence in the combined group was not significantly lower than in the cryotherapy group (P = 0.59). Improvement was observed in the DLQI of all patients in both groups (P = 0.001). No suicidal intention was detected with the C-SSRS. Two patients (one in each group) had liver function test abnormalities after treatment.

Conclusion

Combined therapy showed a slight not significant efficacy for anogenital warts in Hispanic patients. Low-dose isotretinoin seems to be safe even when it is used with cryotherapy on anogenital warts.

Trial registration

On April 25, 2019 with registration number DE19-00004, CONBIOÉTICA-19-CEI-001–20160404. Prospectively registered.

Aubin F, Prétet JL, Jacquard AC et al (2008) Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV). Clin Infect Dis 47:610–615. https://doi.org/10.1086/590560CrossRefPubMed

Ingles DJ, Pierce Campbell CM, Messina JA, Stoler MH, Lin HY, Fulp WJ et al (2014) Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV infection in men (HIM) Study. J Infec Dis. 211(7):1060–1067. https://doi.org/10.1093/infdis/jiu587CrossRef

Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110(5):525–541. https://doi.org/10.1042/CS20050369CrossRef

Christensen ND, Cladel NM, Reed CA, Han R (2000) Rabbit oral papillomavirus complete genome sequence and immunity following genital infection. Virology 269:451–461. https://doi.org/10.1006/viro.2000.0237CrossRefPubMed

Messing AM, Epstein WL (1963) Natural history of warts: a two year study. Arch Dermatol 87:301–310. https://doi.org/10.1001/archderm.1963.01590150022004CrossRef

Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE (2014) British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol 171:696–712. https://doi.org/10.1111/bjd.13310CrossRefPubMed

Stanley MA (2009) Immune responses to human papilloma viruses. Indian J Med Res 130:266–276PubMed

Lacey CJN, Woodhall SC, Wikstrom A et al (2013) 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 27:e263–e270. https://doi.org/10.1111/j.1468-3083.2012.04493.xCrossRefPubMed

Centers for Disease Control. STD treatment guidelines. Available at: http://www.cdc.gov/std/tg2015/. Published 2015. Accessed on June, 22 2020.

10.

Bertolotti A, Dupin N, Bouscarat F, Milpied B, Derancourt C (2017) Cryotherapy to treat anogenital warts in nonimmunocompromised adults: Systematic review and meta-analysis. J Am Acad Dermatol 77(3):518–526. https://doi.org/10.1016/j.jaad.2017.04.012CrossRefPubMed

11.

Stellmach V, Leask A, Fuchs E (1991) Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells. Proc Natl Acad Sci USA 88:45–82CrossRef

12.

Mucida D, Park Y, Kim G et al (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256–260. https://doi.org/10.1126/science.1145697CrossRefPubMed

13.

Jason J, Archibald LK, Nwanyanwu OC (2002) Vitamin A levels and immunity in humans. Clin Diagn Lab Immunol 9:616–621. https://doi.org/10.1128/cdli.9.3.616-621.2002CrossRefPubMedPubMedCentral

14.

Bartsch D, Boye B, Baust C et al (1992) Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11:2283–2291CrossRef

15.

Faluhelyi Z, Rodler I, Csejtey A et al (2004) All-trans retinoic acid (ATRA) suppresses transcription of human papillomavirus type 16 (HPV16) in a dose-dependent manner. Anticancer Res 24:807–809PubMed

16.

Reppucci A, DiLorenzo T, Abramson A et al (1991) In vitro modulation of human laringuela papillota cell differentiation by retinoic acid. Otolaryngol Head Neck Surg 105:528–532. https://doi.org/10.1177/019459989110500404CrossRefPubMed

17.

El-Esawy F, Mustafa AI, El-Shimi O (2019) Serum retinol-binding protein: a novel biomarker for recalcitrant cutaneous warts. Int J Dermatol 58(12):1435–1438. https://doi.org/10.1111/ijd.14475CrossRefPubMed

18.

Olsen EA, Kelly FF, Vollmer RT, Buddin DA, Weck PK (1989) Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol 20(6):1023–1030. https://doi.org/10.1016/s0190-9622(89)70127-4CrossRefPubMed

19.

Cardamakis E, Kotoulas IG, Relakis K, Metalinos K, Michopoulos J, Stathopoulos E et al (1995) Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. Urology 45:857–860. https://doi.org/10.1016/S0090-4295(99)80094-6CrossRefPubMed

20.

Cardamakis EK, Kotoulas IG, Dimopoulos DP, Stathopoulos EN, Michopoulos JT, Tzingounis VA (1996) Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata. Arch Gynecol Obstet 258:35–41. https://doi.org/10.1007/BF01370930CrossRefPubMed

21.

Georgala S, Katoulis AC, Georgala C, Bozi E, Mortakis A (2004) Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: a randomised placebo controlled trial. Sex Transm Infect 80:216–218. https://doi.org/10.1136/sti.2003.006841CrossRefPubMedPubMedCentral

22.

Olguín-García MG, Jurado-Santa Cruz F, Peralta-Pedrero ML, Morales-Sánchez MA (2015) A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts. J Dermatolog Treat 26:78–82CrossRef

23.

Kaur GJ, Brar BK, Kumar S, Brar SK, Singh B (2017) Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial. Int J Dermatol 56(12):1352–1358. https://doi.org/10.1111/ijd.13727CrossRefPubMed

24.

Tsambaos D, Georgiou S, Monastirli A, Sakkis T, Sagriotis A, Goerz G (1997) Treatment of condylomata acuminata with oral isotretinoin. J Urol 158:1810–1812. https://doi.org/10.1016/s0022-5347(01)64136-3CrossRefPubMed

25.

Olguín-García MG, Cancela RG, Peralta-Pedrero ML (2010) Estudio preexperimental para el tratamiento de verrugas planas faciales con isotretinoı’na oral. Dermatol Rev Mex 54:267–272

26.

Al-Hamamy HR, Salman HA, Abdulsattar NA (2012) Treatment of plane warts with a low-dose oral isotretinoin. ISRN Dermatol 2012:163929. https://doi.org/10.5402/2012/163929CrossRefPubMedPubMedCentral

27.

Katz RA (1986) Isotretinoin treatment of recalcitrant warts in an immunosuppressed man. Arch Dermatol 122(1):19–20. https://doi.org/10.1001/archderm.1986.01660130021014CrossRefPubMed

28.

Yildirim M, Inaloz HS, Baysal V, Kesici D, Candir O (2004) A case of condyloma acuminatum treated successfully with low-dose isotretinoin and interferon. Int J Clin Pract 58(9):889–891. https://doi.org/10.1111/j.1742-1241.2004.00071.xCrossRefPubMed

29.

Monastirli A, Matsouka P, Pasmatzi E, Melachrinou M, Georgiou S, Solomou E et al (2005) Complete remission of recalcitrant viral warts under oral isotretinoin in a patient with low-grade b-cell lymphoma. Acta Derm Venereol 1(1):1–1. https://doi.org/10.1080/00015550510027090CrossRef

30.

Miljkovic J (2012) A novel therapeutic approach to plane warts: a report on two cases. Acta Dermatovenerol Alp Pannonica Adriat 21:63–64PubMed

31.

Pasmatzi E, Kapranos N, Monastirli A, Melachrinou M, Georgiou S, Tsambaos D (2012) Large benign condyloma acuminatum: successful treatment with isotretinoin and interferon alpha. Acta Derm Venereol 92(3):249–250. https://doi.org/10.2340/00015555-1257CrossRefPubMed

32.

Yew YW, Pan JY (2013) Complete remission of recalcitrant genital warts with a combination approach of surgical debulking and oral isotretinoin in a patient with systemic lupus erythematosus. Dermatol Ther 27(2):79–82. https://doi.org/10.1111/dth.12059CrossRefPubMed

33.

Jha AK, Sonthalia S, Ganguly S (2018) Oral isotretinoin as an adjunctive treatment for recurrent genital warts. J Am Acad Dermatol 78(2):e35–e36. https://doi.org/10.1016/j.jaad.2017.08.057CrossRefPubMed

34.

Białecka A, Męcińska-Jundziłł K, Adamska U, Cichewicz A, Białecki M, Drewa G, Czajkowski R (2018) Plane warts on the back of the hand successfully treated with oral isotretinoin. Postepy Dermatol Alergol 35(2):227–229. https://doi.org/10.5114/pdia.2017.70259CrossRefPubMedPubMedCentral

35.

Herold M, Nielson C, Longo MI (2018) Isotretinoin and Candida immunotherapy for recalcitrant warts in solid organ transplant recipients. Derm Ther. https://doi.org/10.1111/dth.12803CrossRef

36.

Yang TH, Lee TH, Huang YC (2019) Oral isotretinoin for treating mucocutaneous human papillomavirus infections: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol 85:569–577. https://doi.org/10.4103/ijdvl.IJDVL_269_18CrossRefPubMed

37.

Moreira ED Jr, Giuliano AR, Palefsky J, Flores CA, Goldstone S, Ferris D et al (2014) Incidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men. J Infect Dis 210:192–199. https://doi.org/10.1093/infdis/jiu077CrossRefPubMed

38.

Camargo CC, D’Elia MPB, Miot HA (2017) Quality of life in men affected by anogenital warts. An Bras Dermatol 92(3):427–429. https://doi.org/10.1590/abd1806-4841.20175282CrossRefPubMedPubMedCentral

39.

Al-Awadhi R, Al-Mutairi N, Albatineh AN, Chehadeh W (2019) Association of HPV genotypes with external anogenital warts: a cross sectional study. BMC Infect Dis 19(1):375. https://doi.org/10.1186/s12879-019-4005-4CrossRefPubMedPubMedCentral

40.

Dave DD, Abdelmaksoud A (2019) Low dose Isotretinoin as an adjuvant therapy for treatment of different clinical variants of warts: a case series. Dermatol Ther. https://doi.org/10.1111/dth.12836CrossRefPubMed

41.

Giuliano AR, Sirak B, Abrahamsen M, Silva RJC, Baggio ML, Galan L et al (2019) Genital wart recurrence among men residing in Brazil, Mexico, and the United States. J Infect Dis 219(5):703–710. https://doi.org/10.1093/infdis/jiy533CrossRefPubMed

42.

Sundström A, Alfredsson L, Sjölin-Forsberg G, Gerdén B, Bergman U, Jokinen J (2010) Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ 341:c5812. https://doi.org/10.1136/bmj.c5812CrossRefPubMedPubMedCentral

43.

Huang YC, Cheng YC (2017) Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol 76(6):1068–76.e9. https://doi.org/10.1016/j.jaad.2016.12.028CrossRefPubMed

44.

Singer S, Tkachenko E, Sharma P, Barbieri JS, Mostaghimi A (2019) Psychiatric adverse events in patients taking isotretinoin as reported in a food and drug administration database from 1997 to 2017. JAMA Dermatol 155(10):1162–1166. https://doi.org/10.1001/jamadermatol.2019.1416CrossRefPubMedPubMedCentral

45.

Droitcourt C, Poizeau F, Kerbrat S et al (2019) Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010–2014 French Health Insurance Data. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.16005 (published online ahead of print, 2019 Oct 6)CrossRefPubMed

Titel: Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial
verfasst von: Irving Llibran Reyna-Rodríguez
Sonia Chavez-Alvarez
Veronica Garza-Rodríguez
Rodolfo Franco-Marquez
Gerardo Gonzalez-Martinez
Jorge Ocampo-Candiani
Alejandra Villarreal-Martinez
Publikationsdatum: 12.01.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Dermatological Research / Ausgabe 10/2021
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-020-02182-y

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial

Abstract

Background

Objective

Methods

Results

Conclusion

Trial registration

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Springer Medizin

Abstract

Background

Objective

Methods

Results

Conclusion

Trial registration

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2021

Facilitators of and obstacles to consultation in patients with advanced basal cell carcinoma: a French pilot study

The effect of lyophilized platelet rich-plasma on skin aging: a non-randomized, controlled, pilot trial

Actinic cheilitis or discoid lupus erythematosus?

Validity and reliability of a novel numeric rating scale to measure skin-pain in adults with atopic dermatitis

Dermatopathology practice in the era of COVID-19

Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie